Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice.

Kassan M, Galan M, Partyka M, Trebak M, Matrougui K.

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2534-42. doi: 10.1161/ATVBAHA.111.233262.

2.

Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.

Schlüter T, Steinbach AC, Steffen A, Rettig R, Grisk O.

Cardiovasc Res. 2008 Nov 1;80(2):271-9. doi: 10.1093/cvr/cvn185. Epub 2008 Jul 2.

PMID:
18596059
3.

Augmented EGF receptor tyrosine kinase activity impairs vascular function by NADPH oxidase-dependent mechanism in type 2 diabetic mouse.

Kassan M, Ait-Aissa K, Ali M, Trebak M, Matrougui K.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2404-10. doi: 10.1016/j.bbamcr.2015.05.032. Epub 2015 May 31.

4.

Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice.

Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL.

J Hypertens. 2004 Mar;22(3):535-42.

PMID:
15076159
5.

Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings.

Zemse SM, Hilgers RH, Webb RC.

Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3103-8. Epub 2007 Feb 23.

6.

Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.

Zhou MS, Hernandez Schulman I, Pagano PJ, Jaimes EA, Raij L.

Hypertension. 2006 Jan;47(1):81-6. Epub 2005 Dec 12.

7.

T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury.

Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, Paradis P, Schiffrin EL.

Hypertension. 2011 Mar;57(3):469-76. doi: 10.1161/HYPERTENSIONAHA.110.162941. Epub 2011 Jan 24.

8.

Puerarin protects against endothelial dysfunction and end-organ damage in Ang II-induced hypertension.

Li X, Lin Y, Zhou H, Li Y, Wang A, Wang H, Zhou MS.

Clin Exp Hypertens. 2017;39(1):58-64. doi: 10.1080/10641963.2016.1200603. Epub 2017 Jan 6.

PMID:
28060542
9.

Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.

Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY.

J Pharmacol Exp Ther. 2010 Dec;335(3):553-61. doi: 10.1124/jpet.110.169961. Epub 2010 Sep 15.

10.

Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice.

Kassan M, Galán M, Partyka M, Saifudeen Z, Henrion D, Trebak M, Matrougui K.

Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1652-61. doi: 10.1161/ATVBAHA.112.249318. Epub 2012 Apr 26.

11.

Adoptive transfer of pregnancy-induced CD4+CD25+ regulatory T cells reverses the increase in abortion rate caused by interleukin 17 in the CBA/JxBALB/c mouse model.

Wang WJ, Liu FJ, Xin-Liu, Hao CF, Bao HC, Qu QL, Liu XM.

Hum Reprod. 2014 May;29(5):946-52. doi: 10.1093/humrep/deu014. Epub 2014 Feb 20.

PMID:
24556316
12.

AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.

Wang S, Zhang M, Liang B, Xu J, Xie Z, Liu C, Viollet B, Yan D, Zou MH.

Circ Res. 2010 Apr 2;106(6):1117-28. doi: 10.1161/CIRCRESAHA.109.212530. Epub 2010 Feb 18.

13.

gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension.

Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, Brandes RP.

Circulation. 2004 Apr 13;109(14):1795-801. Epub 2004 Mar 22.

14.

Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation.

Miriyala S, Gongora Nieto MC, Mingone C, Smith D, Dikalov S, Harrison DG, Jo H.

Circulation. 2006 Jun 20;113(24):2818-25. Epub 2006 Jun 12.

15.

Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.

Dinh TN, Kyaw TS, Kanellakis P, To K, Tipping P, Toh BH, Bobik A, Agrotis A.

Circulation. 2012 Sep 4;126(10):1256-66. doi: 10.1161/CIRCULATIONAHA.112.099044. Epub 2012 Jul 31.

16.

Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.

Hiraki S, Ono S, Tsujimoto H, Kinoshita M, Takahata R, Miyazaki H, Saitoh D, Hase K.

Surgery. 2012 Feb;151(2):313-22. doi: 10.1016/j.surg.2011.07.019. Epub 2011 Oct 6.

PMID:
21982068
17.

Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.

Teng L, Liu L, Su Y, Yuan X, Li J, Fu Q, Chen S, Wang C.

J Surg Res. 2011 Dec;171(2):797-806. doi: 10.1016/j.jss.2010.03.044. Epub 2010 Apr 15.

PMID:
20538297
18.

Association of testosterone with estrogen abolishes the beneficial effects of estrogen treatment by increasing ROS generation in aorta endothelial cells.

Costa TJ, Ceravolo GS, dos Santos RA, de Oliveira MA, Araújo PX, Giaquinto LR, Tostes RC, Akamine EH, Fortes ZB, Dantas AP, Carvalho MH.

Am J Physiol Heart Circ Physiol. 2015 Apr 1;308(7):H723-32. doi: 10.1152/ajpheart.00681.2014. Epub 2015 Jan 30.

19.

Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice.

Virdis A, Iglarz M, Neves MF, Amiri F, Touyz RM, Rozen R, Schiffrin EL.

Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1352-7. Epub 2003 Jun 26.

20.

[Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].

Wang ZH, Zhu JY, Li T, Leng XS.

Zhonghua Yi Xue Za Zhi. 2008 Mar 25;88(12):844-7. Chinese.

PMID:
18756991

Supplemental Content

Support Center